Golden Age Health Funding Round

10/28/2026

Venture Equity

Unknown

Undisclosed

The company intends to use the funds to fuel the expansion of its commercial presence and portfolio in Greater China and Asia-Pacific, and accelerate the cross-border flow of biotech innovation between Western markets and Asia.

Private & Independent

Biopharmaceutical

400 Orchard Rd, Orchard Towers 01-11
Singapore, 238875
Singapore

Undisclosed

Golden Age Health (GAH) is a pharmaceutical platform specializing in rare and specialty diseases, creating a vital two-way bridge for innovation. We connect the world's most advanced therapies with patients in China, while simultaneously sourcing high-potential assets from China's maturing biotech ecosystem for global development and commercialization. Our leadership team, comprised of seasoned global pharma executives including the former CEO of Biogen and the architects behind China's most successful rare disease launch (Spinraza), possesses the deep expertise needed to navigate complex business and cultural landscapes. We excel at bridging the gap between brilliant scientist-founders and global commercial success.